• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左旋多巴不会改变帕金森病患者的脑血管反应性。

Levodopa does not change cerebral vasoreactivity in Parkinson's disease.

机构信息

Department of Neuroradiology and MRI, University Hospital of Grenoble, Grenoble, France.

出版信息

Mov Disord. 2013 Apr;28(4):469-75. doi: 10.1002/mds.25267. Epub 2012 Dec 12.

DOI:10.1002/mds.25267
PMID:23238963
Abstract

The aim of this work was to study cerebral vasoreactivity to hypercapnia in Parkinson's disease (PD) before and after levodopa administration. The prospective study was conducted in 20 patients presenting with PD, using 3T blood oxygenation level-dependent (BOLD) functional MRI (fMRI) covering the whole brain. The hypercapnic stimulus was block-designed using carbogen inhalation, a gas mixture of 7% CO2 and 93% O2, before (OFF) and 60 minutes after administration of a suprathreshold (120%) therapeutic L-dopa dose (ON). Ten age-matched controls were enrolled for between-group comparisons. Analyses were conducted with a random effects model and corrected for multiple comparisons. No adverse reaction to the hypercapnic stimulus was reported. However, 10 patients and 2 controls were excluded because of incomplete protocol realization, inappropriate hypercapnic stimulus, or excessive movements, leaving 10 patients and 8 controls for further analyses. The hypercapnic stimulus increased whole-brain BOLD signal of 1.48% ± 0.06% (mean ± standard error) in controls, 1.59% ± 0.05% in patients OFF, and 1.62% ± 0.09% in patients ON. Regions of interest analyses showed a signal increase in gray matter of 2.60% ± 0.16% in controls, 2.89% ± 0.21% in patients OFF, and 2.87% ± 0.12% in patients ON. No global or regional significant difference was detected, when comparing patients OFF and ON L-dopa, or between patients and controls. Contrary to Alzheimer's disease, the vasoreactivity to hypercapnia was normal in PD before and after L-dopa administration, compared to controls. This negative result is an important finding, especially for neuroscientists using fMRI to investigate motricity and cognition, discarding a significant confounding effect.

摘要

本研究旨在探讨帕金森病(PD)患者左旋多巴治疗前后的脑血管对高碳酸血症的反应性。这项前瞻性研究纳入了 20 名 PD 患者,使用覆盖全脑的 3T 血氧水平依赖(BOLD)功能磁共振成像(fMRI)。采用高碳酸血症刺激的气室吸入法,以 7%二氧化碳和 93%氧气的混合气作为刺激气体,在未服用(OFF)和服用超阈值(120%)治疗剂量左旋多巴(ON)后 60 分钟进行。纳入 10 名年龄匹配的对照者进行组间比较。采用随机效应模型进行分析,并校正了多重比较。未报告对高碳酸血症刺激有不良反应。然而,由于方案执行不完整、高碳酸血症刺激不当或过度运动,有 10 名患者和 2 名对照者被排除在外,最终有 10 名患者和 8 名对照者纳入进一步分析。高碳酸血症刺激使对照组全脑 BOLD 信号增加 1.48%±0.06%(均值±标准误差),OFF 期患者增加 1.59%±0.05%,ON 期患者增加 1.62%±0.09%。感兴趣区分析显示,对照组灰质信号增加 2.60%±0.16%,OFF 期患者增加 2.89%±0.21%,ON 期患者增加 2.87%±0.12%。与 ON 期相比,OFF 期患者的 L-dopa 治疗前后或患者与对照者之间,均未检测到全脑或局部信号的显著差异。与阿尔茨海默病不同,与对照组相比,PD 患者在左旋多巴治疗前后对高碳酸血症的血管反应性正常。这一阴性结果是一个重要发现,特别是对于使用 fMRI 研究运动和认知的神经科学家而言,可以排除显著的混杂效应。

相似文献

1
Levodopa does not change cerebral vasoreactivity in Parkinson's disease.左旋多巴不会改变帕金森病患者的脑血管反应性。
Mov Disord. 2013 Apr;28(4):469-75. doi: 10.1002/mds.25267. Epub 2012 Dec 12.
2
l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease.左旋多巴改变帕金森病患者运动序列学习过程中腹侧纹状体的募集。
Behav Brain Res. 2012 Apr 21;230(1):116-24. doi: 10.1016/j.bbr.2012.02.006. Epub 2012 Feb 10.
3
Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.振荡性脑活动减慢是无痴呆帕金森病的一个稳定特征。
Brain. 2007 Jul;130(Pt 7):1847-60. doi: 10.1093/brain/awm034. Epub 2007 Apr 5.
4
Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.左旋多巴影响纹状体的活动,但不影响帕金森病患者皮质的过度活跃。
Eur J Neurosci. 2012 Feb;35(4):572-83. doi: 10.1111/j.1460-9568.2011.07979.x. Epub 2012 Feb 3.
5
Changes of functional connectivity of the motor network in the resting state in Parkinson's disease.帕金森病静息状态下运动网络功能连接的变化
Neurosci Lett. 2009 Aug 21;460(1):6-10. doi: 10.1016/j.neulet.2009.05.046. Epub 2009 May 20.
6
Levodopa-sensitive, dynamic changes in effective connectivity during simultaneous movements in Parkinson's disease.帕金森病患者同时运动时左旋多巴敏感的有效连接动态变化。
Neuroscience. 2009 Jan 23;158(2):693-704. doi: 10.1016/j.neuroscience.2008.06.053. Epub 2008 Jul 3.
7
Impaired cerebral vasoreactivity to CO2 in Alzheimer's disease using BOLD fMRI.使用 BOLD fMRI 观察到阿尔茨海默病患者的脑 CO2 血管反应性受损。
Neuroimage. 2011 Sep 15;58(2):579-87. doi: 10.1016/j.neuroimage.2011.06.070. Epub 2011 Jul 1.
8
Brain dopaminergic modulation associated with executive function in Parkinson's disease.帕金森病中与执行功能相关的大脑多巴胺能调节。
Mov Disord. 2009 Oct 15;24(13):1962-9. doi: 10.1002/mds.22709.
9
The effects of levodopa use on diffusion coefficients in various brain regions in Parkinson's disease.左旋多巴的使用对帕金森病患者不同脑区扩散系数的影响。
Neurosci Lett. 2007 Apr 18;416(3):294-8. doi: 10.1016/j.neulet.2007.02.022. Epub 2007 Feb 11.
10
Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.帕金森病药物洗脱后认知干扰的多巴胺能调节
Brain Res Bull. 2007 Sep 14;74(1-3):75-83. doi: 10.1016/j.brainresbull.2007.05.009. Epub 2007 Jun 6.

引用本文的文献

1
Abnormal Cerebrovascular Activity, Perfusion, and Glymphatic Clearance in Lewy Body Diseases.路易体病中的异常脑血管活动、灌注和神经胶质淋巴清除。
Mov Disord. 2024 Aug;39(8):1258-1268. doi: 10.1002/mds.29867. Epub 2024 May 30.
2
Parkinson's disease cerebrovascular reactivity pattern: A feasibility study.帕金森病脑血管反应性模式:一项可行性研究。
J Cereb Blood Flow Metab. 2024 Oct;44(10):1774-1786. doi: 10.1177/0271678X241241895. Epub 2024 Apr 5.
3
Reduced and Delayed Cerebrovascular Reactivity in Patients with Parkinson's Disease.
帕金森病患者的脑血流反应性降低和延迟。
Mov Disord. 2023 Jul;38(7):1262-1272. doi: 10.1002/mds.29429. Epub 2023 May 8.
4
Cerebrovascular responses to somatomotor stimulation in Parkinson's disease: A multivariate analysis.帕金森病患者躯体运动刺激的脑血管反应:多变量分析。
J Cereb Blood Flow Metab. 2022 Aug;42(8):1547-1558. doi: 10.1177/0271678X211065204. Epub 2022 Mar 15.
5
Cerebral Vasomotor Reactivity in Parkinson's Disease: A Missing Link Between Dysautonomia, White Matter Lesions, and Cognitive Decline?帕金森病中的脑血管舒缩反应:自主神经功能障碍、白质病变与认知衰退之间缺失的环节?
Mov Disord Clin Pract. 2020 Oct 1;7(8):994-995. doi: 10.1002/mdc3.13074. eCollection 2020 Nov.
6
Cerebral blood flow and cerebrovascular reactivity correlate with severity of motor symptoms in Parkinson's disease.脑血流量和脑血管反应性与帕金森病运动症状的严重程度相关。
Ther Adv Neurol Disord. 2019 Mar 21;12:1756286419838354. doi: 10.1177/1756286419838354. eCollection 2019.
7
Unraveling connectivity changes due to dopaminergic therapy in chronically treated Parkinson's disease patients.解析慢性帕金森病患者多巴胺能治疗引起的连接变化。
Sci Rep. 2018 Sep 25;8(1):14328. doi: 10.1038/s41598-018-31988-0.
8
Is impaired cerebral vasoreactivity an early marker of cognitive decline in multiple sclerosis patients?脑循环反应受损是否是多发性硬化症患者认知能力下降的早期标志物?
Eur Radiol. 2018 Mar;28(3):1204-1214. doi: 10.1007/s00330-017-5068-5. Epub 2017 Oct 12.
9
Is cerebral vasomotor reactivity impaired in Parkinson disease?帕金森病患者的脑血管舒缩反应是否受损?
Clin Auton Res. 2017 Apr;27(2):107-111. doi: 10.1007/s10286-017-0406-x. Epub 2017 Feb 20.
10
Magnetic Resonance Techniques Applied to the Diagnosis and Treatment of Parkinson's Disease.应用于帕金森病诊断与治疗的磁共振技术
Front Neurol. 2015 Jul 3;6:146. doi: 10.3389/fneur.2015.00146. eCollection 2015.